M42 And Oracle Collaborate To Enhance Healthy Longevity And Disease Prevention Initiatives

M42, a leader in global health technology, is collaborating with Oracle Health to create comprehensive patient records accessible throughout the UAE. This partnership aims to integrate data from the Emirati Genome Programme into electronic health records (EHR) to support personalised care through pharmacogenomic recommendations. The initiative seeks to enhance healthcare delivery by focusing on prevention and healthy living.

Seema Verma, Executive Vice President at Oracle Health and Life Sciences, stated, "Delivering pharmacogenomic insights at the point of care will help doctors provide more personalised care and prescribe medications that are tailored to a patient’s genetic makeup. This will help increase treatment efficacy, enhance preventive care, and reduce the waste associated with ineffective prescriptions. The work Oracle Health and M42 are undertaking will help promote the long-term health and well-being of UAE’s citizens and aligns with the UAE’s vision of pioneering health innovation and delivering exceptional, patient-centric care."

The collaboration between M42 and Oracle Health involves using the Oracle Health Foundation EHR system. This system will optimise healthcare delivery by prioritising prevention, healthy longevity, and overall well-being. By integrating genomic data directly into EHRs, healthcare providers can offer more data-driven care tailored to individual needs.

Dimitris Moulavasilis, Group CEO at M42, expressed optimism about this programme's impact: "This programme will empower clinicians and patients with actionable insights and enable providers to deliver proactive, personalised care, shaping a healthier future for communities across the UAE. Together with Oracle, we are paving the way for a future where healthcare is predictive, personalised, and accessible to all."

Dr. Fahed Al Marzooqi of M42 highlighted the benefits of informing physicians about genetic compatibility when prescribing medication. This approach increases the chances of prescribing effective medication on the first attempt, leading to quicker treatment outcomes. Such advancements aim to improve recovery times by ensuring that patients receive appropriate treatments based on their genetic profiles.

The initiative aligns with the UAE's vision of advancing health innovation while providing exceptional patient-centred care. By leveraging genomics in healthcare practices, M42 and Oracle Health aim to enhance treatment effectiveness while reducing unnecessary prescriptions.

This collaboration represents a significant step towards achieving a more efficient healthcare system in the UAE. By focusing on personalised medicine through genomic integration into EHRs, both organisations strive to improve overall public health outcomes.

With inputs from WAM